i promise not to ask you not to publish your tax returns if you ask me not to publish my e-mails. and i won t deny things i said in the past. i will admit everything i said. we will try to work our way towards shedding light on something we both think about and write about and talk about a lot. i m going to take the privilege, since it is my book of going first and saying a few things and bob will tell you why what i said was wrong. our subject, is was john quincy adams a realist? we are talking about his worldview. in my book, i say not only did john quincy adams have a worldview, but he probably was the first statesman to have a coherent view, which brought together a sense of domestic policy and foreign policy. i should give a brief shadow shout out because there was a very good short book about atoms that came off while i was writing my book. i mostly, though not wholly agree with what he says. if i had to summarize what my sense of his world view was, it would be s
amazing. futures -57, under 3% measured. challenge.a the euro 1.111. elevated,was really 27. sterling, 1.3625. a difficult go of it. 1322. julie: this is my favorite part of the year. this is the pound index. you can see the incredibly tight correlation all through overnight trading into the morning. only do we see a slight divergence. the white line is the pound index. all such lows, climbing a little bit higher versus the stock getting clobbered. correlationkind of you do not expect to see in your lifetime. scarlet: this is not normal. when you look at how the cash market is doing, it is not that bad in contrast. take a look at the bloomberg. when you break it down into sectors, you have attained main desk you have 10 main groups. companies faring better. the losers are financials, the big banks. we want to show you within the dow the big movers. the dow has 30 members. the only gain is up by half of 1%. stock is down. alix: now let s check in on bloomberg first word news t
Cogent Biosciences Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, has appointed Cole Pinnow as chief commercial officer.
Cogent Biosciences Appoints Cole Pinnow as Chief Commercial Officer tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.